Twist Bioscience And Cancer Research Horizons Partner To Advance Cancer Research
Portfolio Pulse from Benzinga Newsdesk
Twist Bioscience has entered into a partnership with Cancer Research Horizons to advance cancer research. Under the agreement, Cancer Research Horizons will license Twist's Library of Libraries, a collection of synthesized antibody libraries, for five years. Twist will receive a library access fee and may also receive annual maintenance fees and a share of revenue from any assets sold or transferred.
July 18, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The partnership with Cancer Research Horizons could provide Twist Bioscience with a steady stream of revenue over the next five years, which could positively impact its financial performance.
The partnership with Cancer Research Horizons will provide Twist Bioscience with a library access fee and potentially annual maintenance fees and a share of revenue from any assets sold or transferred. This could provide a steady stream of revenue for Twist over the next five years, which could positively impact its financial performance and potentially its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100